Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Polyrizon Advances Preclinical Epilepsy Rescue Treatment Studies
Details : A preclinical study has been initiated for intranasal Benzodiazepines (BZDs), as a first-line treatment for acute repetitive seizures (ARS) and status epilepticus.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
March 25, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Naloxone Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Polyrizon Begins Preclinical Intranasal Naloxone Study for Opioid Overdose Therapy
Details : Naloxone is an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
March 10, 2025
Lead Product(s) : Naloxone Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : PL-14
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Eurofins CDMO
Deal Size : Undisclosed
Deal Type : Agreement
Polyrizon Enters GMP Manufacturing Agreement for PL-14 Allergy Blocker Trial
Details : The collaboration will supply Clinical Trial Material for Polyrizon’s PL-14 allergy blocker, in preparation for a clinical trial.
Product Name : PL-14
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 02, 2024
Lead Product(s) : PL-14
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Eurofins CDMO
Deal Size : Undisclosed
Deal Type : Agreement